SHP-2 inhibitor (VUMC)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSHP-2 inhibitor (VUMC)
Drug Alias NameNSC-87877
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSrc homology phosphotyrosyl phosphatase 2 inhibitors
TargetsSrc homology phosphotyrosyl phosphatase 2
Therapy Area/IndicationsLeukemia, Myeloid, AcuteNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVu University Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVu University Medical Center
Active IndicationsN/A
Inactive IndicationsLeukemia, Myeloid, AcuteNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A